Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 3Head & Neck 1Genitourinary 1

Conditions

Thyroid Nodule 4Squamous Cell Carcinoma of Head and Neck 3Mouth Neoplasms 3Thyroid Neoplasms 2Head and Neck Neoplasms 2Tongue Neoplasms 1Salivary Gland Diseases 1Rectal Neoplasms 1Prostatic Neoplasms 1Neoplasms 1

Interventions

Cetuximab 4pembrolizumab 3Trastuzumab 3Radiotherapy 3Erlotinib Hydrochloride 3Tomography, X-Ray Computed 2Magnetic Resonance Spectroscopy 2Fluorodeoxyglucose F18 2Docetaxel 2Biopsy 2ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1tipifarnib 1sargramostim 1sapanisertib 1relatlimab 1pertuzumab 1palbociclib 1osimertinib 1omipalisib 1oblimersen 1nanocis 1mercaptoundecahydrododecaborate 1larotrectinib 1ipatasertib 1fluoromisonidazole 1erythromycin propionate-N-acetylcysteinate 1erdafitinib 1entinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rectal Neoplasms × Ultrasonography × Head & Neck × Clear all
NCT03908684 2023-12-13

Ultrasound Spectroscopy as Early Indicators of Radiation Treatment Response in Prostate, Rectum and Head & Neck Cancers

Sunnybrook Health Sciences Centre

Recruiting
320 enrolled
GastrointestinalGenitourinaryHead & Neck

Head and Neck Neoplasms, Prostatic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡